Cortisone Acetate
Specifications
50-04-4CAS Number
200-006-5EC Number
[2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetateIUPAC Name
C23H30O6Chemical Formula
402.5 g/molMolecular Weight
CORTISONE ACETATE; 50-04-4; Cortisone 21-acetate; Cortone acetate; Cortisyl; Cortelan; Cortistab; Pregn-4-ene-3,11,20-trione, 21-(acetyloxy)-17-hydroxy-; Cortisone, 21-acetate; Cortisone aceticum; DTXSID0022858; NSC-49420; 17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-acetate; 883WKN7W8X; 21-(Acetyloxy)-17-hydroxypregn-4-ene-3,11,20-trione; DTXCID502858; NSC49420; 17alpha,21-dihydroxypregn-4-ene-3,11,20-trione acetate; 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate; RefChem:54895; 200-006-5; 6alpha,9Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-Butyrate; Cortate; Cortogen; Cortone; Incortin; Biocort acetate; Cortadren; Scheroson; Artriona; Adreson; Irisone acetate; Ricortex; Cortogen acetate; Compound E acetate; Cortisone monoacetate; NSC 49420; Cortilen; Cortisone (acetate); 11-Dehydro-17-hydroxycorticosterone-21-acetate; 11-Dehydro-17-hydroxycorticosterone acetate; MFCD00003609; Cortisone acetate (Standard); MLS000069478; Pregn-4-ene-3,11,20-trione, 17,21-dihydroxy-, 21-acetate; 2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate; NCGC00021191-07; [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate; 4-Pregnene-17a,21-diol-3,11,20-trione 21-acetate; 17,21-Dihydroxypregn-4-ene-3,11,20-trione-21-acetate; Cortisyl artriona; CAS-50-04-4; 2-((1S,10S,11S,15S,2R,14R)-14-hydroxy-2,15-dimethyl-5,17-dioxotetracyclo[8.7.0 .0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl acetate; SMR000059124; CCRIS 3661; Cortisone acetate (Cortone); EINECS 200-006-5; UNII-883WKN7W8X; Cortisone acetate [USP:JAN]; cortisone-acetate; Acetate cortisone; component of Neosone; Cortone 21-acetate; Neosone (Salt/Mix); Cortisone acetate CRS; Cortisone-21-acetate; 21-Acetoxy-17,alpha-hydroxy-3,11,20-triketopregnene-4; 21-Acetoxy-17,alpha-hydroxypregn-4-ene-3,11,20-trione; Cortone acetate (TN); 4-Pregnene-17,alpha,21-diol-3,11,20-trione 21-acetate; SCHEMBL4501; CHEMBL1650; Lopac0_000271; MLS002207136; MLS002548859; CHEBI:3897; orb1224930; orb1310999; orb3139488; CORTISONE ACETATE [JAN]; Cortisone acetate (JP18/USP); Cortisone 21-acetate (Standard); Cortisone 21-acetate, >=99%; CORTISONE ACETATE [VANDF]; CORTISONE ACETICUM [HPUS]; MSK2238; CORTISONE ACETATE [MART.]; HMS2235D24; HMS3259N19; HMS3260H04; HY-17461AR; CORTISONE ACETATE [USP-RS]; CORTISONE ACETATE [WHO-DD]; CORTISONE 21-ACETATE [MI]; Tox21_113482; Tox21_500271; BDBM50455157; EBC-12901; HY-17461A; LMST02030120; MSK2238-100A; SBB080776; AKOS005267225; MSK2238-1000A; Tox21_113482_1; AC-6827; CCG-204366; CORTISONE ACETATE [ORANGE BOOK]; CS-1742; DB01380; FC20559; LP00271; NC00677; SDCCGSBI-0050259.P002; CORTISONE ACETATE [EP MONOGRAPH]; CORTISONE ACETATE [USP MONOGRAPH]; NCGC00021191-03; NCGC00021191-06; NCGC00021191-08; NCGC00021191-09; NCGC00021191-12; NCGC00021191-16; NCGC00260956-01; [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate; 2-[(1R,3aS,3bS,9aR,9bS,11aS)-1-hydroxy-9a,11a-dimethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethyl acetate; AS-13692; ST075179; SY075877; EU-0100271; NS00006620; S2559; C08173; C90609; D00973; AB00384283-08; AB00384283_09; EN300-1709694; F787572; 21-Acetoxy-4-pregnen-17alpha-ol-3,11,20-trione; 21-Acetoxy-17?-hydroxy-3,11,20-triketopregnene-4; BRD-K86161929-001-11-7; BRD-K86161929-001-13-3; HYDROCORTISONE ACETATE IMPURITY D [EP IMPURITY]; Cortisone 21-acetate Solution in Acetonitrile, 100ug/mL; Cortisone Acetate; Hydrocortisone Acetate EP Impurity D; Pregn-4-ene-3,20-trione, 21-(acetyloxy)-17-hydroxy-; Z2238899644; 17,21-Dihydroxypregn-4-ene-3,11,20-trione 21 acetate; 17-Hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate #; 21-Acetoxy-17.alpha.-hydroxy-3,11,20-triketopregnene-4; 21-Acetoxy-17.alpha.-hydroxypregn-4-ene-3,11,20-trione; 4-Pregnen-17.alpha.,21-diol-3,11,20-trione 21-acetate; Cortisone 21-acetate Solution in Acetonitrile, 1000ug/mL; Pregn-4-ene-3,20-trione, 17,21-dihydroxy-, 21-acetate; 4-Pregnene-17.alpha.,21-diol-3,11,20-trione 21-acetate; Cortisone acetate, European Pharmacopoeia (EP) Reference Standard; Pregn-4-ene-3,11,20-trione, 21-(acetyloxy)-17-hydroxy- (9CI); Cortisone acetate, United States Pharmacopeia (USP) Reference Standard; Cortisone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material; 17-hydroxy-3,11,20-trioxopregn-4-en-21-yl acetate (cortisone acetate); 2-((8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate; 877761-70-1Synonyms
